These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 31489705)

  • 1. Association between brain amyloid accumulation and neuropsychological characteristics in elders with depression and mild cognitive impairment.
    Youn H; Lee S; Han C; Kim SH; Jeong HG
    Int J Geriatr Psychiatry; 2019 Dec; 34(12):1907-1915. PubMed ID: 31489705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment.
    Youn H; Lee ES; Lee S; Suh S; Jeong HG; Eo JS
    J Affect Disord; 2018 Oct; 239():30-36. PubMed ID: 29991443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain amyloid accumulation possibly exacerbates concurrent mild cognitive impairment with subthreshold depression in older adults: A 1-year follow-up study.
    Youn H; Hyung WSW; Kim J; Lee ES; Eo JS; Han CE; Han C; Kim SH; Jeong HG
    J Affect Disord; 2021 Dec; 295():93-100. PubMed ID: 34418779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral amyloid accumulation is associated with distinct structural and functional alterations in the brain of depressed elders with mild cognitive impairment.
    Hyung WSW; Kang J; Kim J; Lee S; Youn H; Ham BJ; Han C; Suh S; Han CE; Jeong HG
    J Affect Disord; 2021 Feb; 281():459-466. PubMed ID: 33360748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive Symptoms are Associated with Progression to Dementia in Patients with Amyloid-Positive Mild Cognitive Impairment.
    Moon B; Kim S; Park YH; Lim JS; Youn YC; Kim S; Jang JW;
    J Alzheimers Dis; 2017; 58(4):1255-1264. PubMed ID: 28550264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of cerebral amyloidopathy on regional glucose metabolism in older adults with depression and mild cognitive impairment while performing memory tasks.
    Lee ES; Youn H; Hyung WSW; Suh S; Han CE; Eo JS; Jeong HG
    Eur J Neurosci; 2021 Oct; 54(7):6663-6672. PubMed ID: 34528336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Cognitive Stress Test for the Detection of Preclinical Alzheimer Disease: Discriminative Properties and Relation to Amyloid Load.
    Loewenstein DA; Curiel RE; Greig MT; Bauer RM; Rosado M; Bowers D; Wicklund M; Crocco E; Pontecorvo M; Joshi AD; Rodriguez R; Barker WW; Hidalgo J; Duara R
    Am J Geriatr Psychiatry; 2016 Oct; 24(10):804-13. PubMed ID: 27160985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-amyloid deposition and cognitive function in patients with major depressive disorder with different subtypes of mild cognitive impairment: (18)F-florbetapir (AV-45/Amyvid) PET study.
    Wu KY; Liu CY; Chen CS; Chen CH; Hsiao IT; Hsieh CJ; Lee CP; Yen TC; Lin KJ
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1067-76. PubMed ID: 26739329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain network analysis reveals that amyloidopathy affects comorbid cognitive dysfunction in older adults with depression.
    Lee S; Kim D; Youn H; Hyung WSW; Suh S; Kaiser M; Han CE; Jeong HG
    Sci Rep; 2021 Feb; 11(1):4299. PubMed ID: 33619307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The usefulness of amyloid imaging in predicting the clinical outcome after two years in subjects with mild cognitive impairment.
    Grimmer T; Wutz C; Drzezga A; Förster S; Förstl H; Ortner M; Perneczky R; Kurz A
    Curr Alzheimer Res; 2013 Jan; 10(1):82-5. PubMed ID: 23036071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
    Jansen WJ; Ossenkoppele R; Tijms BM; Fagan AM; Hansson O; Klunk WE; van der Flier WM; Villemagne VL; Frisoni GB; Fleisher AS; Lleó A; Mintun MA; Wallin A; Engelborghs S; Na DL; Chételat G; Molinuevo JL; Landau SM; Mattsson N; Kornhuber J; Sabri O; Rowe CC; Parnetti L; Popp J; Fladby T; Jagust WJ; Aalten P; Lee DY; Vandenberghe R; Resende de Oliveira C; Kapaki E; Froelich L; Ivanoiu A; Gabryelewicz T; Verbeek MM; Sanchez-Juan P; Hildebrandt H; Camus V; Zboch M; Brooks DJ; Drzezga A; Rinne JO; Newberg A; de Mendonça A; Sarazin M; Rabinovici GD; Madsen K; Kramberger MG; Nordberg A; Mok V; Mroczko B; Wolk DA; Meyer PT; Tsolaki M; Scheltens P; Verhey FRJ; Visser PJ; ; Aarsland D; Alcolea D; Alexander M; Almdahl IS; Arnold SE; Baldeiras I; Barthel H; van Berckel BNM; Blennow K; van Buchem MA; Cavedo E; Chen K; Chipi E; Cohen AD; Förster S; Fortea J; Frederiksen KS; Freund-Levi Y; Gkatzima O; Gordon MF; Grimmer T; Hampel H; Hausner L; Hellwig S; Herukka SK; Johannsen P; Klimkowicz-Mrowiec A; Köhler S; Koglin N; van Laere K; de Leon M; Lisetti V; Maier W; Marcusson J; Meulenbroek O; Møllergård HM; Morris JC; Nordlund A; Novak GP; Paraskevas GP; Perera G; Peters O; Ramakers IHGB; Rami L; Rodríguez-Rodríguez E; Roe CM; Rot U; Rüther E; Santana I; Schröder J; Seo SW; Soininen H; Spiru L; Stomrud E; Struyfs H; Teunissen CE; Vos SJB; van Waalwijk van Doorn LJC; Waldemar G; Wallin ÅK; Wiltfang J; Zetterberg H
    JAMA Psychiatry; 2018 Jan; 75(1):84-95. PubMed ID: 29188296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
    Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A; Alegret M; Pesini P; Valero S; Lafuente A; Buendía M; San José I; Ibarria M; Tejero MA; Giménez J; Ruiz S; Hernández I; Pujadas F; Martínez-Lage P; Munuera J; Arbizu J; Tárraga L; Hendrix SB; Ruiz A; Becker JT; Landau SM; Sotolongo-Grau O; Sarasa M; Boada M; ;
    J Alzheimers Dis; 2017; 57(2):447-459. PubMed ID: 28269787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility and acceptance of simultaneous amyloid PET/MRI.
    Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau PET in Alzheimer disease and mild cognitive impairment.
    Cho H; Choi JY; Hwang MS; Lee JH; Kim YJ; Lee HM; Lyoo CH; Ryu YH; Lee MS
    Neurology; 2016 Jul; 87(4):375-83. PubMed ID: 27358341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and
    Ottoy J; Niemantsverdriet E; Verhaeghe J; De Roeck E; Struyfs H; Somers C; Wyffels L; Ceyssens S; Van Mossevelde S; Van den Bossche T; Van Broeckhoven C; Ribbens A; Bjerke M; Stroobants S; Engelborghs S; Staelens S
    Neuroimage Clin; 2019; 22():101771. PubMed ID: 30927601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting.
    Iaccarino L; Chiotis K; Alongi P; Almkvist O; Wall A; Cerami C; Bettinardi V; Gianolli L; Nordberg A; Perani D
    J Alzheimers Dis; 2017; 59(2):603-614. PubMed ID: 28671117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.
    Lim YY; Ellis KA; Harrington K; Kamer A; Pietrzak RH; Bush AI; Darby D; Martins RN; Masters CL; Rowe CC; Savage G; Szoeke C; Villemagne VL; Ames D; Maruff P;
    Neuropsychology; 2013 May; 27(3):322-332. PubMed ID: 23688214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No Association of Lower Hippocampal Volume With Alzheimer's Disease Pathology in Late-Life Depression.
    De Winter FL; Emsell L; Bouckaert F; Claes L; Jain S; Farrar G; Billiet T; Evers S; Van den Stock J; Sienaert P; Obbels J; Sunaert S; Adamczuk K; Vandenberghe R; Van Laere K; Vandenbulcke M
    Am J Psychiatry; 2017 Mar; 174(3):237-245. PubMed ID: 27539488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.